Wish it was a video conference instead. It is really a hit to the shareholders face. Something really feels off as the other investor said if 50% of the acquisition can be sold to Pfizer instead. It seems like the board were very firm, of letting this company go for a measly 11.5c.
Ann: Quarterly Activities Report and Appendix 4C, page-19
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)